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Summary.-Serum concentrations of oestradiol-173 were measured daily through-
out one menstrual cycle in 32 normal women, 31 women with benign disease of the
breast and 10 with cancer of the breast. The concentrations were found to differ
significantly from normal in women with cysts and to a lesser extent in those with
cancer of the breast. In 25 normal post-menopausal and in 27 post-menopausal
women with cancer repeated assays disclosed consistently low levels of oestradiol-
17/f.
IT SEEMS CLEAR that there is a relation-
ship between ovarian function and the
development of both benign and malig-
nant disease of the breast but the nature
of this relationship has not yet been
defined (Hayward, 1972; MacMahon and
Cole, 1972; MacMahon, Cole and Brown,
1973).
The most common benign condition
has been given a variety of names but is
known most often as fibroadenosis (Semb,
1928; Atkins, 1947). It is characterized
clinically by painful, lumpy breasts and
histologically by fibrosis and hyperplasia
ofthe epithelial tissue. Symptoms appear
initially during reproductive life (25-45
years) and disappear at the menopause
(Taylor, 1936; Lewison, 1971). Typically,
they are related to the stage of the
menstrual cycle so that breasts become
painful before menstruation and lumps
which may appear during the luteal phase
of the cycle regress or disappear after
menstruation. Single and multiple cysts
of the breast are also common and may
show cyclical changes similar to those in
fibroadenosis. They are considered by
many to be a manifestation of the same
condition. The cyclical nature of the
clinical features and their limitation to the
period ofreproductive life suggest strongly
an endocrine cause; similar changes in-
cluding cysts may be produced in labora-
tory animals by prolonged administration
of oestrogens (Goormaghtigh and Amer-
linck, 1930; Burrows, 1935).
Several studies of urinary oestrogen
excretion in patients with cancer of the
breast have been reported but the results
are conflicting and confusing (Brown,
1958; Bacigalupo and Schubert, 1960;
Trvine et al., 1961; Jull, Shucksmith and
Bonser, 1963; Nissen-Meyer and Sanner,
1963; Perrson and Risholm, 1964; Mar-
morston et al., 1965; Lemon et al., 1966;
Schweppe, Jungman and Lewin, 1967;
Arguelles et al., 1973).
Measurement of urinary oestrogens is
an unsatisfactory method of investigation
for several reasons. Oestrogen production
varies according to the stage of the
menstrual cycle and there are practical
difficulties in acquiring the multiple com-
plete 24 h specimens needed to represent
the whole cycle. Most oestrogen is meta-
bolized in the liver and does not appear in572 P. C. ENGLAND, L. G. SKINNER, K. M. COTTRELL AND R. A. SELLWOOD
the urine and that proportion which does
may bear little relationship to that present
in the body fluids.
Measurement of oestrogens in blood
should provide a more practical and
accurate solution and this is now possible
by means of radioimmuunoassay (Cameron
and Jones, 1972). In a previous study
(England et al., 1974), we measured by
this method the concentration of oestra-
diol-17fl in samples of blood from normal
women. We found that in pre-meno-
pausal women the pattern of oestradiol
was remarkably constant but that con-
centrations varied with age. Women in
the fourth decade of life had significantly
higher concentrations than either younger
or older women. In this study we have
compared our findings in normal women
with those in benign and malignant
diseases of the breast.
MATERIALS AND METHODS
Subjects-.Samples of blood were taken
daily or as often as possible during at least
one menstrual cycle from pre-menopausal
women as follows: (a) 32 normal women wvith
no history of breast disease. The results in
30 normal women were reported in a previous
paper (England et al., 1974). The addition of
two more since this publication has not
TABLE. M3ain Concentrations of
Oestradiol-17,/ in 32 Normal Women
Age group
20-29
30-39
40-49
Serum oestradiol-17fl pg/ml -
s.e. mean
, ~ ~ ~~A
No. of Follicular Luteal
cycles phase phase
12
10
10
39 - 0±4 - '32
36-3±44 88
32- 1 5-86
67-4 2-4
82 -5t2 - 92
65- 1±1-92
altered significantly the normal range (Table).
Twelve subjects were aged 20-29 years,
10 aged 30-39 years and 10 aged 40-49 years;
(b) 31 wN-omen with benign disease of the
breast; 18 had painful lumpy breasts; 6 -were
aged 20-29 years; 7 aged 30-39 years and 5
aged 40-49 years. The remaining 13 had had
one or more cysts aspirated from one or both
breasts. Of these 5 w-ere aged 30-39 years
and 8 aged 40-49 years; (c) 10 wTomen with
cancer of the breast aged 40-49 years.
Multiple samples (264) w-ere also obtained
from 25 normal post-menopapsal women
betwAeen 47 and 64 years (mean age 56 years)
and from 25 post-menopausal women with
cancer of the breast (320) aged 52-79 years
(mean age 63 years).
None ofthe subjects studied had a history
of gynaecological disease or was taking any
hormonal preparation.
Collection of blood sanmples.-Peripheral
venous blood (approximately 10 ml) was
collected daily between 9 a.m. and 12 noon.
The blood was allowed to clot, centrifuged
and the serum removed and stored at -20°C.
Measurement of serum oestradiol-173.-
Radioimmunoassay of oestradiol-17/3 was
carried out by the method described pre-
viously (Cameron and Jones, 1972; England
et al., 1974). By counting the radioactive
supernatant sample (0.5 ml) in 10 ml ofa 1 : 1
dilution with Scintillator Grade Xylene of
PCS-Liquid scintillation cocktail (Hopkins
and Williams, Chadw%Aell Heath, Essex) count-
ing efficiency was rasied to approximately
38%o.
Expression of results.-The lengths of the
cycles varied greatly, so that a reference point
other than the first day of the cycle was
needed for comparative purposes. The day
of the mid-cycle peak of oestradiol-17/3 was
used as the reference poinit and designated as
Day 0. Preceding days wN-ere given negative
numbers and the days following positive
numbers. Days -11 to - 4 w%iere referred
to as the follicular phase and Day + 4 to +
12 as the luteal phase. Groups were compared
bythestatisticalmethodofpaired comparison.
RESULTS
A. Benign disease
1. In women with painful lumpy
breasts the results were essentially normal
and the variation in results was less than
that in normal women. When individual
profiles were compared with the mean
profile for normal women the range of
differences was as follows:
(a) 20-29 age group.-Follicular phase
- 14-6 to +9 2 pg/ml (normalrange 17-2
to +1 3 1.). Luteal phase -1 0 to +1 4 6
pg/ml (normal range 29 6 to +32 7).SERUM OESTRADIOL-17/I IN WOMEN
(b) 30-39 age group.-Follicular phase
-11 4 to +51*1 pg/ml (normal range
-22*6 to +22 2). Luteal phase 29-0
to +37 3 pg/ml (normal range 51 6 to
+43 6).
(c) 40-49 age group. Follicular phase
-8X8 to +22 0 pg/ml (normal range
-1441 to +18.2). Luteal phase 32 7
to +30'7 pg/ml (normal range 34-6 to
+54 3).
2. In women with cysts the mean
concentration of oestradiol-17,8 during the
240a
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I
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o 80 w
40
28*4 + 2*1 (s.e. mean) pg/ml (P < 0.001)
(Fig. 2). Of the 8 women, 4 had signi-
ficantly higher values than normal, 2 of
which were unusually high (190.2 + 13 4
s.e. mean pg/ml and 120 4 ± 10 7 s.e.
mean pg/ml). Only one woman had a
value which was less than normal. In
the follicular phase ofthe cycle the results
were similar to those for normal women.
B. Cancer of the breast
In both the follicular and luteal phases
ORMAL
(STIC DISEASE
l I
/ I
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FIG. 1. MAeani concenitrations of oestra(liol-17/ in normal pre-menopatisal women aged 30-39 years
andl in wAomen with cysts. Pairedl comparisons in luteal phase P < 0-01.
luteal phase of the cycle was significantly
higher than that of normal women. Of
the 5 women in the 30-39 year age group,
3 had significantly higher values than
normal and only one had a lower value.
The overall mean difference was 18 0
+ 5 8 (s.e. mean) pg/ml (P < 0.01) (Fig. 1).
The overall mean difference of the
women in the 40-49 year age group was
of the cycle the mean concentrationi of
oestradiol-17/? in patients with cancer of
the breast was slightly but significantly
greater than that in normal women
(Fig. 3). In the follicular phase (Day -11
to Day 4), using the method of paired
comparison, the overall mean difference
was 6 1 + 2*3 (s.e. mean) pg/ml (P < 0.05)
and in the luteal phase (Day +4 to
v w
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FIG. 2. Mean concentration of oestradiol-17fl in normal pre-menopausal women aged 40-49 years
Wand in women with cysts. Paired comparisons in luteal phase P < 0 001.
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Fie. 3. MIean concentration of oestradiol-17fi in normal pre-menopausal women aged 40-49 vears
and in women with cancer of the breast. Paired comparisons in follicular phase P < 005 an(d
in luteal phase P < 0'05.
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Day +12) 9 0 ± 3.5 (s.e. mean) pg/ml
(P < 0.05). A comparison of means,
however, is probably an unsatisfactory
way of expressing these data, which were
characterized by much greater individual
variations than those observed in any of
the other groups studied. For example,
in the follicular phase of the cycle 6 of the
10 patients with cancer had values which
differed by more than 15 pg/ml from the
mean in normal women compared with
only one of 10 normals (P < 0.05). Of
these 6, 4 had high concentrations and 2
had low ones. In post-menopausal women
the concentrations of oestradiol-17,8 were
consistently low both in normal women
(5.78 + 0 33 (s.e. mean) pg/ml) and in
women with cancer of the breast (7-38
+ 0-39 (s.e. mean) pg/ml).
DISCUSSION
In women with painful lumpy breasts
the concentrations of oestradiol-17,8 were
normal and this finding is consistent with
the suggestion that the syndrome is
merely an exaggeration of a normal
physiological state (Bonser, Dossett and
Jull, 1961). In those with cysts, the
concentrations were significantly high
during the luteal phase of the cycle and 2
women in the 40-49 age group had
exceptionally high values. Cystic disease
may well be a separate entity with an
aetiology different from that of the condi-
tion usually described as fibroadenosis.
A critical histological study of non-
malignant conditions of the breast is
needed so that we can define our terms
more accurately.
The results in pre-menopausal women
with cancer of the breast varied greatly
and were difficult to interpret. In both
follicular and luteal phases the mean
concentrations were significantly greater
than those in normal women, but this
finding may give a misleading impression.
The striking feature was the marked
variation in either direction from the
mean normal profile. Greater numbers
will need to be studied before the abnor-
mality can be defined clearly. Several
studies have indicated a relationship
between cancer ofthe breast and previous
benign disease (Warren, 1940; Logie,
1942; Foote and Stewart, 1945; Lewison
and Lyons, 1953; Hodge, Surver and
Aponte, 1959; Humphrey and Swerdlow,
1962), in particular cysts (Haagensen,
1971). Our data suggest there may be a
similar endocrine abnormality in both
cancer and benign cystic disease.
The endocrine background to cancer
of the breast is unlikely to be explained
by measurement of a single hormone.
Oestriol and progesterone, which are con-
sidered by some to exert a protective
effect (Lemon et al., 1966; MacMahon et
al., 1973), require detailed study.
In post-menopausal women, with or
without cancer of the breast, the con-
centrations of oestradiol-17,8 were ex-
tremely low and at the lower limit of the
sensitivity of our assay. It might be
more rewarding to study oestrone, the
concentrations ofwhich are relatively high
in post-menopausal women (Rader et al.,
1973).
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